FINDINGS OF SCIENTIFIC MISCONDUCT Release Date: February 11, 1999 P.T. Department of Health and Human Services Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following cases: Ms. Janell Bodily, B.S., M.S.W., University of Utah: Based on the report of an investigation conducted by the University of Utah and information obtained by ORI during its oversight review, ORI finds that Ms. Bodily, former interviewer, Health Education Department, College of Health, University of Utah, engaged in scientific misconduct in research supported by a National Institute of Mental Health (NIMH), National Institutes of Health (NIH) grant. Specifically, Ms. Bodily intentionally falsified patient signatures and responses to questions for at least 75 patient interviews for an NIMH-funded research project, \"Evaluation of the Utah Prepaid Mental Health Plan,\" which involved indigent patients. The study required annual interviews of the participating subjects. The falsified information was damaging to the research project because researchers had to expend substantial time and additional money to re-interview patients. Because the data for the previous year could not be recollected, the response rate for that year was substantially below the response rate for other years of the study and may have reduced the overall statistical reliability of the multi-year study. None of the questioned data has been included in publications. ORI has implemented the following administrative actions for the three (3) year period beginning January 25, 1999: (1) Ms. Bodily is prohibited from any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in nonprocurement transactions (e.g., grants and cooperative agreements) of the United States Government as defined in 45 C.F.R. Part 76 (Debarment Regulations); and (2) Ms. Bodily is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. Mr. Thomas Philpot, R.N., B.S.N., Rush-Presbyterian-St. Luke\'s Medical Center and Northwestern University: Based on the report of an investigation conducted by Rush-Presbyterian-St. Luke\'s Medical Center (RPMC), a report of an inquiry conducted by Northwestern University, and information obtained by ORI during its oversight review, ORI finds that Mr. Philpot, former data manager for the National Surgical Adjuvant Breast and Bowel Project (NSABP) at RPMC and McNeal Cancer Center, formerly an NSABP affiliate of Northwestern University, engaged in scientific misconduct in clinical research supported by two National Cancer Institute (NCI), National Institutes of Health (NIH) cooperative agreements. Specifically, Mr. Philpot intentionally falsified and/or fabricated follow-up data on seven separate reports related to three patients enrolled in NSABP clinical trials for breast cancer (B-09, B-12, and B-22). The falsified and/or fabricated data were submitted to the NSABP Biostatistical Center on NSABP reporting forms and were recorded in the NSABP research records maintained at the clinical sites. ORI has implemented the following administrative actions for the three (3) year period beginning January 19, 1999: (1) Mr. Philpot is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) any institution that submits an application for PHS support for a research project on which Mr. Philpot\'s participation is proposed or which uses him in any capacity on PHS supported research, or that submits a report of PHS-funded research in which he is involved, must concurrently submit a plan for supervision of his duties to the funding agency for approval. The supervisory plan must be designed to ensure the scientific integrity of Mr. Philpot\'s research contribution. The institution also must submit a copy of the supervisory plan to ORI. INQUIRIES For further information contact: Acting Director Division of Research Investigations Office of Research Integrity 5515 Security Lane, Suite 700 Rockville, MD 20852 Telephone: (301) 443-5330
